Zobrazeno 1 - 10
of 1 728
pro vyhledávání: '"Osunkoya A"'
Autor:
Kaushal, Seema, Jain, Ekta, Acosta, Andres M., Sangoi, Ankur R., Lobo, Anandi, Jha, Shilpy, Sharma, Shivani, Arora, Samriti, Beg, Arshi, Akgul, Mahmut, Williamson, Sean R., Baisakh, Manas R., Pattnaik, Niharika, Satturwar, Swati, Parwani, Anil V., Dixit, Mallika, Malik, Vipra, Osunkoya, Adeboye O., Cheng, Liang, Amin, Mahul B., Dhillon, Jasreman, Mishra, Sourav K., Biswas, Ghanashyam, Panda, Soumya Surath, Mohanty, Sambit K.
Publikováno v:
In Human Pathology November 2024 153
Publikováno v:
In Pathology - Research and Practice April 2024 256
Autor:
Soltani, Soheil, Ojaghi, Ashkan, Qiao, Hui, Kaza, Nischita, Li, Xinyang, Dai, Qionghai, Osunkoya, Adeboye O, Robles, Francisco E
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer remains a significant clinical challenge. To shed light on this problem, we develop an approach based on multispectral deep-ultraviolet (UV) microscopy that p
Externí odkaz:
http://arxiv.org/abs/2106.00682
Autor:
Chen Zhengjia, Fan Songqing, Yang Xiaojian, Iqbal Shareen, Osunkoya Adeboye O, Zhau Haiyen E, Zhang Shumin, Wang Ruoxiang, Marshall Fray F, Chung Leland WK, Wu Daqing
Publikováno v:
Molecular Cancer, Vol 9, Iss 1, p 9 (2010)
Abstract Background Myeloid cell leukemia-1 (Mcl-1) is a member of the Bcl-2 family, which inhibits cell apoptosis by sequestering pro-apoptotic proteins Bim and Bid. Mcl-1 overexpression has been associated with progression in leukemia and some soli
Externí odkaz:
https://doaj.org/article/d4c1a8c73fd44a37a8585ac8a46c4545
Autor:
Aron, Manju, Chandrashekar, Darshan S., Canete-Portillo, Sofia, Brimo, Fadi, Williamson, Sean R., Osunkoya, Adeboye O., Raspollini, Maria Rosaria, Kunju, Lakshmi P., Varambally, Sooryanarayana, Mackinnon, Alexander C., Harada, Shuko, Netto, George J.
Publikováno v:
In Modern Pathology December 2023 36(12)
Autor:
McDonald John F, Logani Sanjay, Osunkoya Adeboye O, Laycock Noelani, Scharer Christopher D, Benigno Benedict B, Moreno Carlos S
Publikováno v:
Journal of Translational Medicine, Vol 6, Iss 1, p 79 (2008)
Abstract Background A large percentage of patients with recurrent ovarian cancer develop resistance to the taxane class of chemotherapeutics. While mechanisms of resistance are being discovered, novel treatment options and a better understanding of d
Externí odkaz:
https://doaj.org/article/ad1de9f5912743d1bfe27765fb7c746b
Autor:
Viraj A. Master, Benjamin N. Schmeusser, Adeboye O. Osunkoya, Arnold R. Palacios, Eric Midenberg, Lauren Yantorni, Kenneth Ogan, Mehmet A. Bilen
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 50-55 (2023)
Renal cell carcinoma with level IV tumor thrombus is a condition necessitating aggressive surgical management. Many solid organ malignancies often benefit from neoadjuvant treatments for tumor debulking and improvement of surgical outcomes. However,
Externí odkaz:
https://doaj.org/article/2cfee0fda685443bbd43014795ab61f2
Publikováno v:
In Pathology - Research and Practice April 2023 244
Autor:
Cheng, Liang, Lopez-Beltran, Antonio, Wang, Mingsheng, Whaley, Rumeal D., De Souza, Andre, Au, Sammy, Ge, Rongbin, Cimadamore, Alessia, Amin, Ali, Golijanin, Borivoj, MacLennan, Gregory T., Osunkoya, Adeboye O., Montironi, Rodolfo, Zhang, Shaobo
Publikováno v:
In Modern Pathology March 2023
Autor:
Mahmut Akgul, Robert Humble, Abdullah Osme, Servet Yuce, Elif N. Kocak, Parisa Najafzadeh, Ankur Sangoi, Niharika Pattnaik, Sourav Mishra, Shivani Sharma, Nada Shaker, Seema Kaushal, Manas Baisakh, Andrea R. Lightle, Bonnie L. Balzer, Guang-Qian Xiao, Gregory T. MacLennan, Adeboye O. Osunkoya, Anil Parwani, Liang Cheng, Andrew Bellizzi, Sambit K. Mohanty
Publikováno v:
Diagnostic Pathology, Vol 17, Iss 1, Pp 1-9 (2022)
Highlights Clear cell adenocarcinoma of the lower urinary tract is rare, with heterogenous morphology. GATA3 expression can be seen in these tumors, causing diagnostic challenge in the urinary tract or in the metastatic setting. Along with morphologi
Externí odkaz:
https://doaj.org/article/a13b80eadd6f4057b0a3d25f73462a24